# Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay

> **NCT00839202** · NA · COMPLETED · sponsor: **Children's Hospital Los Angeles** · enrollment: 7 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **OTHER:** FVIII immuno-assay

## Key facts

- **NCT ID:** NCT00839202
- **Lead sponsor:** Children's Hospital Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-09
- **Final completion:** 2009-02
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839202, "Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00839202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*